Clinical trial AZUR-2 219606
A Phase 3, Double-Arm, Open-Label Study of Peri-operative Dostarlimab Monotherapy versus standard of care in Participants with Untreated Stage II/III dMMR/MSI-H
Cancers | |
---|---|
Organ | Multiple |
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Interventional with experimental drug
|
Phase | Trial phase 3 |
Academic trial | Non |
Sponsor | GSK |
EudraCT Identifier | 2023-503265-27-00 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05855200 |
Last update |